Exelixis (EXEL) Interest Coverage Ratio (QoQ) (2010 - 2018)
Exelixis (EXEL) Interest Coverage Ratio (QoQ) (2010 - 2018) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
| 1 |
Alterity Therapeutics |
719,706.53 Bn |
719,706.50 Bn |
- |
| 2 |
Belite Bio |
55,800.00 Bn |
55,800.00 Bn |
- |
| 3 |
Quantum Biopharma |
18,182.30 Bn |
18,182.29 Bn |
- |
| 4 |
Legend Biotech |
3,154.00 Bn |
3,153.71 Bn |
242.10 Mn |
| 5 |
Akari Therapeutics |
1,844.30 Bn |
1,844.29 Bn |
- |
| 6 |
Evaxion A |
1,567.96 Bn |
1,567.94 Bn |
- |
| 7 |
Psyence Biomedical |
251.43 Bn |
251.42 Bn |
- |
| 8 |
Vertex Pharmaceuticals |
112.56 Bn |
105.31 Bn |
2.59 Bn |
| 9 |
Abivax |
94.37 Bn |
94.37 Bn |
- |
| 10 |
Exelixis |
13.37 Bn |
12.59 Bn |
590.86 Mn |
| Date | Value |
|---|
| Dec 28, 2018 |
-189.16% |
| Jun 30, 2017 |
39.39% |
| Mar 31, 2017 |
-69.94% |
| Dec 30, 2016 |
1,538.69% |
| Sep 30, 2016 |
138.55% |
| Jun 30, 2016 |
49.63% |
| Sep 30, 2015 |
-36.29% |
| Jun 30, 2015 |
-42.54% |
| Mar 31, 2015 |
79.20% |
| Dec 31, 2014 |
-110.12% |
| Sep 30, 2014 |
17.76% |
| Jun 30, 2014 |
7.58% |
| Mar 31, 2014 |
53.09% |
| Dec 31, 2013 |
-140.77% |
| Sep 30, 2013 |
-7.18% |
| Jun 30, 2013 |
-48.38% |
| Mar 31, 2013 |
34.03% |
| Dec 31, 2012 |
-40.71% |
| Sep 30, 2012 |
58.57% |
| Jun 30, 2012 |
-43.61% |
